Five Major ASC-Related Deals and Investment Moves in 2026
Becker’s ASC Review says ASCs had their biggest deal year on record in 2026 and highlights five major ASC-related transactions and investment moves. They are not all surgery-center…
-
-
Penn Medicine, IBX, and Regent Surgical Launch Tri-Party Company to Build 18+ Philadelphia ASCs
What is the new Penn Medicine, Independence Blue Cross, and Regent Surgical partnership? The three organizations have formed a new jointly owned company to develop at least 18…
-
How RCM Performance Drives ASC Valuation Multiples in 2026
Ambulatory surgery centers preparing to sell in 2026 are seeing buyers price deals on revenue cycle performance as much as case volume, according to VMG Health. Historical ASC…
-
CMS 2027 Outpatient Pay Proposal: 2.4% Increase, 340B Cuts and Site-Neutral Expansion
CMS is proposing a 2.4% increase in outpatient and ambulatory surgical center payments for 2027, alongside a cut to the 340B drug discount and a broader push toward…
-
Ascension’s $3.9B AmSurg Deal Signals New ASC Antitrust Era
Ascension completed its $3.9 billion acquisition of AmSurg on June 4, 2026, expanding its ambulatory surgery center network from 58 to more than 300 facilities across 34 states…
-
ASC M&A in 2026: Health Systems and PE Compete for Surgery Center Assets
Ambulatory surgery center M&A remains active in 2026, with private equity and health systems both accelerating acquisition pace. Tenet Healthcare’s USPI deployed $125 million in Q1 2026 alone…
-
FTC Clears Ascension’s $3.9B AmSurg Deal with ASC Divestitures in 5 Markets
The FTC approved Ascension’s $3.9 billion acquisition of AmSurg, the nation’s largest independent ambulatory surgery center operator, under a consent order issued June 2, 2026. To preserve competition,…